Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia
Leukemia, 07/17/2012
Chillon MC et al. – The findings indicate that high FLT3 expression identifies MLL–AF4+acute lymphoblastic leukemia (ALL) patients at very high risk of treatment failure and poor survival, emphasizing the value of ongoing/future clinical trials for FLT3 inhibitors.



